The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia - Wikidata - awgldk - TriplyDB

The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia

The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia

http://www.wikidata.org/entity/Q24650739

about

Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Medications development for opioid abuse Opioid-induced central immune signaling: implications for opioid analgesia Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP.The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.Toll-like Receptor-Dependent Negative Effects of Opioids: A Battle between Analgesia and Hyperalgesia.Shared mechanisms for opioid tolerance and a transition to chronic pain.Toll-like receptor 9 is required for opioid-induced microglia apoptosis.Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine.Opioid activation of toll-like receptor 4 contributes to drug reinforcement Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment.Glial TLR4 signaling does not contribute to opioid-induced depression of respiration.Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids.Evidence for brain glial activation in chronic pain patients.Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens.Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.Scratching activates microglia in the mouse spinal cord Chronic morphine-induced microRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6.Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis.Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine.Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.Morphine activates neuroinflammation in a manner parallel to endotoxin A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.Emerging role of Toll-like receptors in the control of pain and itch.

P2860

Q23916279-BAE02C5C-D060-4FA3-87B5-7EE487FA53AC Q24612607-88C44596-10B6-4DB1-A431-176FCCDE5039 Q24622752-D12CB964-0CCA-4829-8E1E-6C948A676B8A Q26768068-61F56F77-826C-418F-BF1E-BA90F752DE49 Q26829556-6A9B7A1A-2E8F-410D-B8E5-383A0813F885 Q26853370-EA8AA0A5-509D-4E7C-8799-D429F1C004B7 Q27021477-1543AD94-2049-4269-AF11-A248EEFE26E8 Q27300742-94179114-CA0D-4E73-BA9B-5BCE50F6410A Q28081406-9768B798-F194-47C6-889A-63672EE02D51 Q28085351-4231ABF6-CF78-4019-B693-F61F7565C54A Q28274052-D7312FA3-CD15-4918-8E6D-1CAF7DC3D9A5 Q33709318-1B4956EF-E485-4445-B0E7-5B9AD0B6227D Q33727021-E5FF2BCC-D4C0-4C76-940F-8075766F48C9 Q33742394-1229BA20-ED5C-465C-8612-0039A283D9F8 Q33803874-1568FDD5-D19C-4CAC-9463-2FD8D4C96B00 Q33895294-6C787E18-EA4B-40BC-A5F7-B5D5FC2D11BB Q33971397-C601CD69-43E9-4111-A48C-D1512E727455 Q34294203-365645AA-3847-4046-8BC9-215579732181 Q34311105-D6B03867-1C95-4BDA-BC9F-88F7EEDE13A4 Q34353901-1A720B54-8709-46B2-A69A-349E199EC169 Q34399068-19DAF6E4-38E2-4084-A368-1C527D71BD90 Q34457857-73104342-2A64-4E7C-BB39-BF0DA60616BF Q34569178-7AE3A29A-1A90-4CA4-B9DC-915287B4F4EA Q34603199-F4B980F7-7489-4220-A504-34BC8E3E01F9 Q34640959-39D8C48E-FD83-480F-B76F-2556E1C73B43 Q34943639-9C0274CE-AB86-485A-8671-DBBE85FEB3AE Q34980268-80139489-DA67-48C0-A60C-EB045DFA7B87 Q35087100-9E132A34-2D63-4492-B54C-8F3F3AC6AA7D Q35122783-12D865C8-0D76-4A0C-B477-9A9E067ED1E6 Q35124986-39B3B1D6-6ED3-4573-B0AF-9705DC331B68 Q35194571-794499B9-C34F-448E-A8AC-AF4C7CB070B6 Q35619740-B77BF833-4886-4E91-B4AF-4CA6AF5314C5 Q35681383-6E632B84-F73B-4A9B-AC16-962774AEE43F Q35779664-BE4E03FA-E21A-42D6-BF60-9838E9263882 Q35814647-740B51E1-4F09-4694-B4B6-3BB87EF4D343 Q35833987-FD1BDFD2-965F-406A-A305-BDED615FC28F Q35855634-67C2D43A-7615-43C7-9BB2-08451C5BAC94 Q35924760-171F6E00-58D3-4A7B-9700-7828993A91D1 Q35928226-FCD9418D-DE07-465D-9666-2E199C896EC0 Q35944972-FB462915-2989-4228-AAC0-8417E9558C9C

P2860

The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia

http://www.wikidata.org/entity/Q24650739

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@ast

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@en

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@nl

type

label

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@ast

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@en

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@nl

prefLabel

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@ast

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@en

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@nl

P1433

Q24650739-53B866AA-E823-4CFA-9111-AD30464E2C63

P1476

Q24650739-282F5BA4-70BE-4B9B-B261-0C10D29FCA38

P2093

Q24650739-2CC363A3-39F4-47E6-9AC1-FDD78F5693CD

Q24650739-FB62ADE7-CA32-481C-A50A-2215E77ADC30

P2860

Q24650739-047A1B90-5B47-4ED5-8198-A21B55499FCD

Q24650739-053F3FA6-D34B-4E3D-A336-3784C16F8C4F

Q24650739-0D5BDF00-7D93-4EE5-984C-7EF397EDB664

Q24650739-1AF2DC28-BD50-4ECA-9400-7BEC693984ED

Q24650739-1E8BEEBA-7CDB-4AD2-8A8E-A723BB2843D0

Q24650739-2607ED1A-5F2B-439E-93AF-534FF6649629

Q24650739-271841A0-8060-4EF9-8DE8-C51DF58BEEBC

Q24650739-27495B50-A546-47FE-8B0F-EAF012E232AC

Q24650739-2785602A-F4E1-44F9-8484-AC1923543650

Q24650739-29DED2D4-2827-4B23-AA7A-405F6CCCEA00

P304

Q24650739-099400F3-8507-4798-8DA2-B7CEF08D9C54

P31

Q24650739-C4D731D5-F358-4E41-B4E5-A7E48F250ED5

P3181

Q24650739-682179AA-D4D8-4B82-A45A-BAED48DA8924

P356

Q24650739-5F6B6C9F-36E5-46BA-8777-FEA6AE7FF058

P407

Q24650739-B6C8F46B-0758-4FBE-967F-48F0211135B9

P433

Q24650739-5EA91CE5-0E0F-418B-8905-5532E13B3AE0

P478

Q24650739-6E27398D-E9C0-444E-AE89-E0679F21FF66

P50

Q24650739-052E7A5F-9B85-43D4-91E7-A45AB1B31131

Q24650739-B2E2F8C4-6B59-44D3-A537-140F44E36848

P577

Q24650739-246A3717-9FEA-49CD-8A8A-CE8DBDF8EAAE

P5875

Q24650739-5D795C8B-3802-4C21-B23C-0740921F606A

P698

Q24650739-B3FC55A2-C3A2-4421-865B-F1429B29E414

P921

Q24650739-33590725-6E9E-42DD-8D86-541CDE4ED68B

Q24650739-9E715196-3AC7-4108-A8C3-F8D52046370C

P932

Q24650739-B410E5D5-4FB1-439D-8172-8150EFE0C0AE

P3181

P356

J.TIPS.2009.08.002

P1433

Trends in Pharmacological Sciences

P1476

The "toll" of opioid-induced g ...... y of opioids by targeting glia

@en

P2093

Kenner C Rice

http://www.w3.org/2001/XMLSchema#string

Steven F Maier

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological and protective roles of glia in chronic pain

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia

Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse

Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10

Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance

Mechanisms underlying morphine analgesic tolerance and dependence

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)

Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury

Morphine enhances microglial migration through modulation of P2X4 receptor signaling

P304

581-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1673172

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.TIPS.2009.08.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Linda R. Watkins

Mark R. Hutchinson

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26819686

http://www.w3.org/2001/XMLSchema#string

P698

19762094

http://www.w3.org/2001/XMLSchema#string

P921

P932

2783351

http://www.w3.org/2001/XMLSchema#string